Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial

JAMA

Volumn 282, Issue 16, 1999, Pages 1568-1575

  Heymsfield, Steven B ^a   Greenberg, Andrew S ^b   Fujioka, Ken ^c   Dixon, Russell M ^d   Kushner, Robert ^e   Hunt, Thomas ^f   Lubina, John A ^g   Patane, Janet ^g   Self, Barbara ^g   Hunt, Pam ^g   McCamish, Mark ^g  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c SCRIPPS CLINIC   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f PPD Pharmaco   (United States)

^g AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; RECOMBINANT LEPTIN; RECOMBINANT METHIONYLLEPTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ECCHYMOSIS; ERYTHEMA; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

EID: 0032747280     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.16.1568     Document Type: Article

References (29)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372:425-432.
2. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269:540-543.
3. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543-546.
4. Campfield LA, Smith FJ, Cuisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;259:546-549.
5. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387:903-908.
6. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155-1161.
7. Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A. 1996;93:1726-1730.
8. Pelleymounter MA, Cullen MJ, Healy D, Hecht R, Winters D, McCaleb M. Efficacy of exogenous recombinant murine leptin in lean and obese 10-to 12-mo-old female CD1 mice. Am J Physiol. 1998;275(4 pt 2):R950-R959.
9. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334: 292-295.
10. Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest. 1995;95:2986-2988.
11. Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med. 1995;1:950-953.
12. Hamilton BS, Paglia D, Kwan AY, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med. 1995;1:953-956.
13. Ahrén B, Larsson H, Wilhelmsson C, Näsman B, Olsson T. Regulation of circulating leptin in humans. Endocrine. 1997;7:1-8.
14. Considine RV, Caro JF. Leptin and the regulation of body weight. Int J Biochem Cell Biol. 1997;29: 1255-1272.
15. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet. 1996;348:159-161.
16. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med. 1996;2:589-593.
17. Mantzoros C, Flier JS, Lesem MD, Brewerton TD, Jimerson DC. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab. 1997;82:1845-1851.
18. Pietrobelli A, Formica C, Wang ZM, Heymsfield SB. Dual-energy x-ray absorptiometry body composition model: review of physical concepts. Am J Physiol. 1996;271:941-951.
19. Mazess RB, Barden H, Bisek J, Hanson J. Dual energy x-ray absorptiometry for total body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990;51:1106-1112.
20. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. JAMA. 1996;276:637-639.
21. Lau D, Lubina J, Dixon RM, et al. Pharmacokinetics of recombinant methionyl human leptin (rL) and the effect of antibody formation in lean and obese subjects following subcutaneous (SC) dosing. Poster presented at: The 8th International Congress on Obesity; August 29-September 3, 1998; Paris, France.
22. Fujioka K, Patane J, Lubina J, Lau D. CSF leptin levels after exogenous administration of recombinant methionyl human leptin. JAMA. 1999;282:1517-1518.
23. Shi ZQ, Nelson A, Whitcomb L, Wang J, Cohen AM. Intracerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats. Metabolism. 1998; 47:1274-1280.
24. VanHeek M, Compton DS, France CF, et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest. 1997;99:385-390.
25. Seeley RJ, van Dijk G, Campfield LA, et al. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats Horm Metab Res. 1996;28:664-668.
26. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;34:879-884.
27. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature. 1998;392:398-401.
28. Mallard SP, Selby LL, Khoo H-M, Cheung EN-G, Young JD, Lau DT-W. Pharmacokinetics of recombinant methionyl human leptin (rmetHuLeptin) in male CD1 mice. Pharm Res. 1997;14:S78-S79.
29. Taylor SI, Barr V, Reitman M. Does leptin contribute to diabetes caused by obesity? Science. 1996; 274:1151-1152.